Last10K.com

1Life Healthcare Inc (ONEM) SEC Filing 10-Q Quarterly Report for the period ending Friday, September 30, 2022

SEC Filings

ONEM Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ONEM Annual Reports

ONEM Quarterly Reports

ONEM Corporate News

ONEM Merger Prospectus

ONEM Registration of Securities

1Life Healthcare Inc

HISTORY TOOLS
CIK: 1404123 Ticker: ONEM

Exhibit 99.1
One Medical Announces Results for Third Quarter 2022
•Third Quarter 2022 Ending Total Membership Count of 815,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 775,000 and At-Risk Membership Count of 40,000
•Third Quarter 2022 Net Revenue of $261.4 Million, a 73% Increase Year-Over-Year
SAN FRANCISCO – November 2, 2022 – 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced financial results for the third quarter ended September 30, 2022.
“Through our human-centered and technology-powered model, we continue to perform, innovate, and grow to delight more members with better health, better care, and lower costs, in a better team environment,” said Amir Dan Rubin, Chair & CEO of One Medical. “Our One Medical model continues to deliver longitudinal care across digital and in-person settings to members of all ages.”
Financial Highlights for the Third Quarter 2022
All comparisons are to the three months ended September 30, 2021. Unless otherwise noted, our results of operations in this press release include the activity of Iora Health, Inc. ("Iora") beginning from the close of our acquisition on September 1, 2021.
•Total membership count as of quarter-end was 815,000 compared to 715,000, a 14% increase; Consumer and Enterprise membership count of 775,000 and At-Risk membership count of 40,000 as of quarter-end.
•Net Revenue was $261.4 million compared to $151.3 million, a 73% increase.
•Medical Claims Expense Ratio was 78%.
•Loss from Operations was $117.3 million, or 45% of Net Revenue; Net Loss was $112.0 million, or 43% of Net Revenue.
•Care Margin was $48.5 million, or 19% of Net Revenue.
•Adjusted EBITDA was a loss of $39.8 million, or 15% of Net Revenue.
•Cash and marketable securities of $267.2 million as of September 30, 2022.
Due to the company's pending transaction with Amazon, One Medical will not be providing guidance for the fourth quarter 2022 and is suspending its financial guidance for the full fiscal year 2022.
In addition, as is customary during the pendency of an acquisition, One Medical will not be hosting a conference call in conjunction with its third quarter 2022 earnings release. For further details and discussion of our financial performance please refer to our quarterly report on Form 10-Q for the quarter ended September 30, 2022.
Key Metrics and Non-GAAP Financial Measures
Members: Members include both Consumer and Enterprise members as well as At-Risk members as defined below. Our number of members depends, in part, on our ability to successfully market our services directly to consumers including Medicare-eligible as well as non-Medicare eligible individuals, to Medicare Advantage health plans and Medicare Advantage enrollees, to employers that are not yet enterprise clients, as well as our activation rate within existing enterprise clients. We define estimated activation rate for any enterprise client at a given time as the percentage of eligible lives enrolled as members. While growth in the number of members is an important indicator of expected revenue growth, it also informs our management of the areas of our business that will require further investment to support expected future member growth. Member numbers as of the end of each period are rounded to the thousands.

The following information was filed by 1Life Healthcare Inc (ONEM) on Wednesday, November 2, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate 1Life Healthcare Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 1Life Healthcare Inc.

Continue

Assess how 1Life Healthcare Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

1Life Healthcare Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Legal
M & A
Other
Filter Subcategory:
All
Shares
Expense
Product
Cash Flow
Earnings
Income
Other
Inside 1Life Healthcare Inc's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Loss
Condensed Consolidated Statements Of Operations
Condensed Consolidated Statements Of Stockholders' Equity (Deficit)
Business Combinations
Business Combinations (Tables)
Business Combinations - Acquisition Of Iora, Additional Information (Details)
Business Combinations - Adjustments To Pro Forma Information (Details)
Business Combinations - Intangible Assets Acquired (Details)
Business Combinations - Loan Agreement (Details)
Business Combinations - Other Acquisitions (Details)
Business Combinations - Purchase Price Allocation (Details)
Business Combinations - Purchase Price Components (Details)
Business Combinations - Unaudited Pro Forma (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Convertible Senior Notes
Convertible Senior Notes (Tables)
Convertible Senior Notes - Additional Information (Details)
Convertible Senior Notes - Summary Of Interest Expense Recognized Related To Convertible Senior Notes (Details)
Convertible Senior Notes - Summary Of Net Carrying Amount Of Liability Component Of Convertible Senior Notes (Details)
Fair Value Measurements And Investments
Fair Value Measurements And Investments (Tables)
Fair Value Measurements And Investments - Additional Information (Details)
Fair Value Measurements And Investments - Investments (Details)
Fair Value Measurements And Investments - Schedule Of Financial Assets And Liabilities Measured At Fair Value On Recurring Basis (Details)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (Tables)
Goodwill And Intangible Assets - Estimated Future Amortization (Details)
Goodwill And Intangible Assets - Goodwill (Details)
Goodwill And Intangible Assets - Intangible Assets And Accumulated Amortization (Details)
Income Taxes
Income Taxes (Details)
Leases
Leases (Tables)
Leases - Additional Information (Details)
Leases - Components Of Operating Lease Costs (Details)
Leases - Future Minimum Lease Payments Under Non-Cancellable Operating Leases (Details)
Leases - Lease Term And Discount Rate (Details)
Leases - Supplemental Cash Flow Information (Details)
Nature Of The Business And Basis Of Presentation
Nature Of The Business And Basis Of Presentation (Tables)
Nature Of The Business And Basis Of Presentation - Additional Information (Details)
Nature Of The Business And Basis Of Presentation - Reconciliation Of Cash, Cash Equivalents And Restricted Cash (Details)
Nature Of The Business And Basis Of Presentation - Summary Of Customers Representing 10% Or More Of Accounts Receivables (Details)
Nature Of The Business And Basis Of Presentation - Summary Of Customers Representing 10% Or More Of Net Revenue (Details)
Net Loss Per Share
Net Loss Per Share (Tables)
Net Loss Per Share - Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share (Details)
Net Loss Per Share - Schedule Of Basic And Diluted Net Loss Per Share (Details)
Note Receivable
Note Receivable (Details)
Proposed Acquisition By Amazon
Proposed Acquisition By Amazon (Details)
Related Party Transactions
Revenue Recognition
Revenue Recognition (Tables)
Revenue Recognition - Activity In Ibnr Claims (Details)
Revenue Recognition - Additional Information (Details)
Revenue Recognition - Capitated Accounts Payable, Net (Details)
Revenue Recognition - Capitated Accounts Receivable, Net (Details)
Revenue Recognition - Schedule Of Contract Assets And Deferred Revenue (Details)
Revenue Recognition - Schedule Of Remaining Performance Obligation (Details)
Revenue Recognition - Summary Of Net Patient Service Revenue By Source (Details)
Revenue Recognition - Summary Of Net Revenue (Details)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - 2020 Employee Stock Purchase Plan, Additional Information (Details)
Stock-Based Compensation - Assumed Equity Awards (Details)
Stock-Based Compensation - Stock Incentive Plan, Additional Information (Details)
Stock-Based Compensation - Stock Options, Additional Information (Details)
Stock-Based Compensation - Summary Of Rsu Activity (Details)
Stock-Based Compensation - Summary Of Stock Option Activity (Details)
Stock-Based Compensation - Summary Of Stock-Based Compensation Expense (Details)
Stock-Based Compensation - Tranches Of Performance Stock Option (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Variable Interest Entities
Variable Interest Entities (Details)

Material Contracts, Statements, Certifications & more

1Life Healthcare Inc provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: ONEM
CIK: 1404123
Form Type: 10-Q Quarterly Report
Accession Number: 0001404123-22-000076
Submitted to the SEC: Wed Nov 02 2022 4:56:09 PM EST
Accepted by the SEC: Wed Nov 02 2022
Period: Friday, September 30, 2022
Industry: Offices And Clinics Of Doctors Of Medicine

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/onem/0001404123-22-000076.htm